Kenvue Inc. Reports Second‑Quarter 2026 Results
Kenvue Inc. (NYSE: KVUE) released its financial results for the second quarter of 2026 on 6 August 2026. The company posted a net income of $456 million, or $0.24 per share, up from $420 million ( $0.22 per share ) in the same period last year. Adjusted earnings, which exclude one‑time items, reached $595 million or $0.31 per share, a 32 % increase from the prior year.
Revenue for the quarter amounted to $3.96 billion, representing a 3.0 % rise year‑over‑year. This figure fell short of analysts’ consensus estimates by $10 million, and the non‑GAAP earnings per share of $0.31 missed the consensus by $0.01. The company attributed the margin pressure to higher inflation and tariff costs that weighed on its supply‑chain expenses.
Kenvue’s operating model remains focused on consumer health products in the self‑care, skin‑health, and beauty segments. As of 4 August 2026, the stock closed at $19.67 per share, with a 52‑week high of $21.96 (12 August 2025) and a low of $14.02 (29 October 2025). The company’s market capitalization is $37.5 billion, and its price‑earnings ratio stands at 22.93.
The results indicate that, despite external cost pressures, Kenvue continues to grow revenue and earnings, though it remains slightly below the consensus expectations for the quarter. The company’s guidance for the remainder of the year was not disclosed in the current release.
